3.15% 0.70

Arrowhead Pharmaceuticals Inc (ARWR)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt ARWR? Forum Prognose Aktiensplit

Warum fällt Arrowhead Pharmaceuticals Inc-Aktie (ARWR)?

Wir haben während der Handelssitzung 2024-09-06 einen Rückgang der Aktie Arrowhead Pharmaceuticals Inc (ARWR) um 5.20% festgestellt. Obwohl dies auf normale Volatilität oder verschiedene interne und externe Faktoren zurückzuführen sein kann, beachten Sie bitte, dass wir die Situation aktiv beobachten und so schnell wie möglich zeitnahe Updates bereitstellen!

2023-11-30:

Arrowhead Pharmaceuticals Inc. Stock (ARWR) dropped by 26.85% from $28.98 to $21.20 in the trading on Thursday November 30, 2023. The reasons why ARWR stock down today include:

**Net loss **: Arrowhead Pharmaceuticals, Inc. today announced its financial results for the fourth quarter and full year ended September 30, 2023. Arrowhead announced a net loss of $205.3 million for the fiscal year ended September 30, 2023, compared to a net loss of $176.1 million for the previous fiscal year.
Missed results: Arrowhead Pharmaceuticals reported fiscal year GAAP EPS of -$1.92, missing the consensus by $0.41. Revenue of $240.73 million, slightly down from $243.2 million in the previous year. Revenue figures missed the consensus by $22.85M.
Increase in expenses: Arrowhead Pharmaceuticals Inc's fiscal year was marked by significant investment in research and development (R&D), with expenses rising to $353.2 million from $297.3 million in the previous year. This increase reflects the company's commitment to advancing its pipeline of RNAi therapeutics.

2023-07-07:

Arrowhead Pharmaceuticals Stock (ARWR) stock decreased 3.53% to $33.32 due to some notable insider selling from the biotech’s senior leadership, namely, Tracie Oliver, ARWR’s Chief Commercial Officer.

https://seekingalpha.com/news/3986290-why-did-arrowhead-stock-dip-today